Search all medical codes

Injection, rituximab, 10 mg

HCPCS code

Name of the Procedure:

Injection, rituximab, 10 mg (J9312)

  • Common Name: Rituximab Injection
  • Medical Term: Rituximab 10 mg Intravenous Injection

Summary

Rituximab injection is a medical procedure where rituximab, a medication used to treat certain autoimmune diseases and types of cancer, is administered directly into the bloodstream. This therapy involves injecting 10 mg of rituximab per designated dose via an intravenous (IV) line.

Purpose

Rituximab is used to treat various conditions, including:

  • Certain types of Non-Hodgkin lymphoma
  • Chronic lymphocytic leukemia
  • Rheumatoid arthritis
  • Certain autoimmune diseases, such as granulomatosis with polyangiitis and microscopic polyangiitis

The goal is to reduce symptoms, control disease progression, and improve the overall quality of life.

Indications

  • Diagnosed Non-Hodgkin lymphoma or chronic lymphocytic leukemia.
  • Severe or refractory rheumatoid arthritis.
  • Autoimmune conditions unresponsive to initial therapies.
  • Patients generally in good health but require treatment for these specific disorders.

Preparation

  • Fasting is typically not required.
  • Adjustments to current medications might be necessary (consult your physician).
  • Pre-procedure blood tests or imaging studies.
  • Hydration is recommended before the procedure.

Procedure Description

  1. Initial Setup: The patient is positioned comfortably, and an IV line is established.
  2. Preparation of Medication: Rituximab is prepared in a sterile environment under strictly controlled conditions.
  3. Administration:
    • A test dose may be given initially to monitor for any allergic reaction.
    • The required dose of rituximab is administered slowly through the IV line over several hours.
  4. Monitoring: Continuous monitoring of vital signs and patient status is conducted throughout the infusion.

Tools and Equipment:

  • IV line and administration set
  • Infusion pump
  • Sterile syringes and needles
  • Monitoring devices

Anesthesia or Sedation: None usually required; however, pre-medications like antihistamines or corticosteroids may be given to minimize allergic reactions.

Duration

The infusion usually takes 3-6 hours, depending on the protocol and patient response. Subsequent infusions may be shorter.

Setting

This procedure is typically performed in:

  • Hospital outpatient departments
  • Specialized infusion clinics
  • Oncology centers

Personnel

  • Oncologist or Rheumatologist
  • Registered Nurse (RN)
  • Infusion Specialist
  • Pharmacist
  • Emergency response team available on-site

Risks and Complications

Common Risks:

  • Mild to moderate allergic reactions (e.g., rash, itching, fever)
  • Infusion reactions (e.g., headache, chills)

Rare but Serious Risks:

  • Severe allergic reactions (anaphylaxis)
  • Tumor lysis syndrome in patients with large tumor burdens
  • Infections due to immune suppression
  • Cardiac issues, particularly in patients with pre-existing conditions

If complications arise, immediate medical intervention is warranted.

Benefits

  • Reduction in disease symptoms.
  • Slowing or stopping disease progression.
  • Potential remission in certain cancers.
  • Possible rapid symptom relief within days for some conditions.

Recovery

  • Most patients can go home the same day.
  • Mild fatigue or discomfort may be experienced post-infusion.
  • Normal activities can generally be resumed, but strenuous activities might be restricted for a day or two.
  • Follow-up appointments to monitor the response and manage any side effects.

Alternatives

  • Other biologic therapies or immunosuppressive medications.
  • Conventional chemotherapy for some cancers.
  • Alternative disease-modifying anti-rheumatic drugs (DMARDs).
  • Pros: Alternatives may have fewer infusion-related reactions.
  • Cons: Alternatives might not be as effective for some patients.

Patient Experience

During the Procedure:

  • Mild discomfort from IV insertion.
  • Possible cold sensation at the infusion site.
  • Monitoring by healthcare professionals for immediate intervention if needed.

After the Procedure:

  • Mild fatigue and the need to stay hydrated.
  • Detailed post-procedure care instructions will be provided.
  • Pain management and comfort measures include over-the-counter pain relievers if needed.

Overall, rituximab infusion is a well-established procedure with significant benefits for those it serves, despite some risks.

Similar Codes



Contact us to learn more

Choose your own adventure

Email

Send us a message or questions and we can share more details.

Meet

Setup a calendar meeting with us; find a time now.